Greenwich Historical Cash Flow
| GLSI Stock | USD 14.25 0.32 2.20% |
Analysis of Greenwich Lifesciences cash flow over time is an excellent tool to project Greenwich Lifesciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 4 K or Capital Expenditures of 0.0 as it is a great indicator of Greenwich Lifesciences ability to facilitate future growth, repay debt on time or pay out dividends.
Greenwich |
About Greenwich Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Greenwich balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Greenwich's non-liquid assets can be easily converted into cash.
Greenwich Lifesciences Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Greenwich Lifesciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Greenwich Lifesciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Greenwich Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.Total Cash From Financing Activities is expected to grow at the current pace this year, while Change In Cash is forecasted to increase to (6.2 M).
Greenwich Lifesciences cash flow statement Correlations
Click cells to compare fundamentals
Greenwich Lifesciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Greenwich Lifesciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (78.3K) | 28.7M | (1.5M) | (13.7M) | (6.5M) | (6.2M) | |
| Free Cash Flow | (293.3K) | (1.2M) | (4.3M) | (6.2M) | (6.5M) | (6.2M) | |
| Change In Working Capital | 2.9M | 28.4K | (385.2K) | (122.3K) | 31.5K | 29.9K | |
| Begin Period Cash Flow | 85.1K | 6.8K | 28.7M | 27.2M | 13.5M | 12.7M | |
| Other Cashflows From Financing Activities | 215K | (360K) | 2.8M | (7.5K) | (8.7K) | (8.2K) | |
| Total Cash From Operating Activities | (293.3K) | (1.2M) | (4.3M) | (6.2M) | (6.5M) | (6.2M) | |
| Net Income | (3.4M) | (1.9M) | (4.6M) | (7.8M) | (8.9M) | (8.4M) | |
| End Period Cash Flow | 6.8K | 28.7M | 27.2M | 13.5M | 7.0M | 6.6M |
Currently Active Assets on Macroaxis
When determining whether Greenwich Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Greenwich Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Greenwich Lifesciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Greenwich Lifesciences Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Greenwich Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Return On Assets (0.72) | Return On Equity (1.24) |
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.